My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidlines Journals & Publications Policy & Advocacy Meetings About IDSA
July 2008
Volume 18, Number 7
CDC Updates Recommendations on Prevention, Control of Influenza

The Centers for Disease Control and Prevention has issued newly updated recommendations for the prevention and control of influenza, in advance of the 2008-2009 flu season. CDC’s Advisory Committee on Immunization Practices recommends the following:

  • Annual vaccination should be administered to all children ages 5-18 years, beginning in the 2008-2009 season, if feasible, but not no later than 2009-2010.
  • Efforts should primarily target children aged 6 months through 4 years because these children are at higher risk for influenza complications.
  • Either trivalent inactivated influenza vaccine or live, attenuated influenza vaccine (LAIV) should be used when vaccinating healthy persons aged 2-49 years (the previous recommendation for LAIV was for people aged 5-49 years)
  • Providers should use vaccines containing the 2008-09 trivalent vaccine virus strains A/Brisbane/59/2007 (H1N1)-like, A/Brisbane/10/2007 (H3N2-like), and B/Florida/4/2006-like antigens.

The report includes new information on antiviral resistance. Oseltamivir-resistant influenza A (H1N1) strains have been identified in the United States and some other countries. However, oseltamivir or zanamivir continue to be the recommended antivirals for treatment of influenza because other influenza virus strains remain sensitive to oseltamivir, and resistance levels to other antiviral medications remain high.

The full report can be found in MMWR, July 17, 2008/57(Early Release);1-60.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


New Encephalits Guidelines Published
HIV Opportunistic Infections Guidelines Updated
IDSA Journal Club, July 2008
In the IDSA Journals
ACIP Makes New Recommendations on Rabies, HPV, Pneumococcal Vaccines
CDC Updates Recommendations on Prevention, Control of Influenza
Zoster Vaccine Recommended for All Persons Over 60
EIN: MAI Disease and Clofazimine
Drug Approvals, Recalls, Adverse Events Update
Congress Stops Steep Medicare Physician Payment Cuts, For Now
CMS to Launch New Website to Compare Physicians
U.S. Global AIDS Program Expands
Federal ID Budgets Likely to See Small Increases
IDSA Advocacy Update: IDSA Opposes Federal Antiviral, Antibiotic Stockpiling Plans
IDSA/SHEA Infection Control Fellows Course Available Online
Looking For CME Opportunities?
Congratulations, New IDSA Fellows!
IDSA 2008 Elections Coming Up
Members on the Move
Welcome, New IDSA Members!
View archived IDSA News issues
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'idsa@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.